MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience Total Liabilities 2011-2026 | VIVO
Annual Total Liabilities Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 135 M | 76 M | 80.2 M | 85.4 M | 17.4 M | 15.9 M | 21.7 M | 18.6 M | 17 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 135 M | 15.9 M | 51.8 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.32 B | $ 114.84 | -0.55 % | $ 34.9 B |  USA |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
2.13 M | $ 2.59 | 1.37 % | $ 84.1 K | USA |
|
Biodesix
BDSX
|
76.4 M | $ 15.32 | 1.66 % | $ 1.99 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
29.2 M | $ 1.19 | -1.25 % | $ 6.48 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.57 | 2.28 % | $ 178 M | China |
 |
CareDx, Inc
CDNA
|
110 M | $ 18.37 | 0.33 % | $ 979 M | USA |
 |
Celcuity
CELC
|
366 M | $ 113.92 | 1.14 % | $ 5.33 B | USA |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 167.82 | -3.49 % | $ 8.32 B | USA |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 24.95 | 0.44 % | $ 693 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 198.98 | 0.92 % | $ 22.1 B | USA |
 |
Danaher Corporation
DHR
|
31.8 B | $ 191.91 | 0.41 % | $ 137 B | USA |
 |
DexCom
DXCM
|
3.59 B | $ 63.19 | 1.56 % | $ 24.7 B | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 16.66 | -0.95 % | $ 504 M | USA |
 |
Guardant Health
GH
|
2.11 B | $ 90.61 | -3.44 % | $ 11.4 B | USA |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 111.56 | -2.31 % | $ 9.2 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 128.04 | 0.52 % | $ 20.4 B | USA |
 |
IQVIA Holdings
IQV
|
23.3 B | $ 171.32 | -1.12 % | $ 29.4 B | USA |
 |
Invitae Corporation
NVTA
|
1.85 B | - | - | $ 21.2 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 275.75 | 0.74 % | $ 22.9 B | USA |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 76.36 | 0.35 % | $ 5.15 B | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 490.0 | -1.67 % | $ 14.1 B | USA |
 |
Organovo Holdings
ONVO
|
4.16 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
2.48 M | - | -16.95 % | $ 1.54 M | USA |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 257.33 | -0.21 % | $ 25.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
339 M | $ 4.78 | 0.63 % | $ 443 M | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 M | $ 4.51 | -3.84 % | $ 3.55 M | USA |
 |
NeoGenomics
NEO
|
523 M | $ 8.0 | - | $ 1.02 B | USA |